ACTG 5197: A Placebo Controlled Trial of Immunization of HIV-1 Infected Persons with a Replication Deficient Ad5 Vaccine Expressing the HIV-1 Core Protein

BACKGROUND: HIV-1 specific cellular immunity contributes to control of HIV-1 replication. HIV-1 infected volunteers on antiretroviral therapy received a replication defective Ad5 HIV-1 gag vaccine in a randomized, blinded therapeutic vaccination study. METHODS: HIV-1-infected vaccine or placebo reci...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schooley, Robert T., Spritzler, John, Wang, Hongying, Lederman, Michael M., Havlir, Diane, Kuritzkes, Daniel R., Pollard, Richard, Battaglia, Cathy, Robertson, Michael, Mehrotra, Devan, Casimiro, Danilo, Cox, Kara, Schock, Barbara
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2010
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2916952/
https://ncbi.nlm.nih.gov/pubmed/20662716
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/655468
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge